by kefea | Mar 17, 2016 | Αrticles |
* By Kyriakos Mikellis In most European countries, unlike Cyprus, policies on pharmaceuticals give patients access to the treatment their doctors consider the most appropriate. Pharmaceuticals and pharmaceutical care are usually the responsibility of three independent...
by kefea | Jun 30, 2014 | Αrticles |
*Joanna Kozakou In recent years there has been a growing interest in the nature of the pharmaceutical industry’s relationships with healthcare professionals and healthcare organizations, particularly because patients and the public at large want to be sure that...
by Elena | Apr 10, 2014 | Αrticles |
By Joanna Kozakou Issues directly relevant to Cyprus were recently discussed at the “Sustainable Health Systems for Inclusive Growth in Europe” conference, organised under the auspices of the Lithuanian Presidency in Vilnius. Representatives of all Member States,...
by Elena | Jul 17, 2013 | Αrticles |
*By Joanna Kozakou States are under unprecedented pressure to achieve the correct balance between universal access to high quality Health services and adhering to budgetary constraints. As the European Union’s Commissioner for Health and Consumer Policy, Tonio Borg,...
by Elena | Jun 13, 2013 | Αrticles |
*by Jacqueline Anastassiades Cyprus is at the start of a very difficult era for its economy, with a multitude of negative consequences on a number of aspects of everyday life. The state, but also the private sector, is trying to put the economy back on a course of...
by Elena | Nov 30, 2012 | Αrticles |
*By Petros Mavrogenis We have recently been observing the difficulties and challenges faced by many European states. Cutting costs is imperative. Today, more than ever, we must not view costs as mere expenditures but more as an investment, which will bring long term...
by Elena | Oct 9, 2012 | Αrticles |
Did you know that it takes on average 12 years for a new medicine to get from the lab to the shelves of your Pharmacy? Did you know that only 5 in every 5.000 compounds that enter the preclinical testing phase actually make it to human testing? Did you know that only...
by Elena | Sep 12, 2012 | Αrticles |
*by Jacqueline Anastassiades Innovation in the pharmaceutical sector is a characteristic of medical progress in general and has contributed dramatically to increasing population survival or improving disease management. Innovation is present in all sectors of economic...
